Published in J Infect Dis on October 07, 2013
Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS Med (2014) 1.68
A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin. J Infect Dis (2015) 1.65
"Inconvenient truths" in the pursuit of scientific knowledge and public health. J Infect Dis (2013) 1.10
Draft Genome Sequence of Bivalent Clostridium botulinum Strain IBCA10-7060, Encoding Botulinum Neurotoxin B and a New FA Mosaic Type. Genome Announc (2014) 1.01
Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal Chem (2015) 1.00
The past and future of RRI. Life Sci Soc Policy (2014) 0.97
Clarification regarding novel Clostridium botulinum toxin. J Infect Dis (2014) 0.97
Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells. PLoS One (2014) 0.92
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library. MAbs (2014) 0.91
Functional characterisation of germinant receptors in Clostridium botulinum and Clostridium sporogenes presents novel insights into spore germination systems. PLoS Pathog (2014) 0.91
Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II. Res Microbiol (2014) 0.91
Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype. PLoS One (2015) 0.91
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Nat Struct Mol Biol (2016) 0.90
Redaction of sensitive data in the publication of dual use research of concern. MBio (2013) 0.88
Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502. Appl Environ Microbiol (2014) 0.87
Two novel toxin variants revealed by whole-genome sequencing of 175 Clostridium botulinum type E strains. Appl Environ Microbiol (2014) 0.86
Validity of botulinum neurotoxin serotype H. J Infect Dis (2014) 0.86
Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System. Appl Environ Microbiol (2014) 0.86
Botulism outbreaks in natural environments - an update. Front Microbiol (2014) 0.85
Botulinum Neurotoxin Subtype A4 Originating from Nontoxigenic Clostridium botulinum. Appl Environ Microbiol (2014) 0.85
Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm. PLoS One (2014) 0.85
Antimicrobial resistance is a global health emergency. Health Secur (2015) 0.84
Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. J Infect Dis (2016) 0.84
Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin. Prog Biophys Mol Biol (2015) 0.83
Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A. Antimicrob Agents Chemother (2014) 0.83
A new synthesis for dual use research of concern. PLoS Med (2015) 0.83
Genetic characterization and comparison of Clostridium botulinum isolates from botulism cases in Japan between 2006 and 2011. Appl Environ Microbiol (2014) 0.83
Why has Not There been More Research of Concern? Front Public Health (2014) 0.83
Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites. PLoS One (2014) 0.82
DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge. Hum Vaccin Immunother (2015) 0.81
Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains. Appl Environ Microbiol (2014) 0.80
Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery. Curr Opin Struct Biol (2015) 0.80
Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia. Cell Microbiol (2015) 0.79
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain. mSphere (2016) 0.79
Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2. Front Neurol (2014) 0.79
Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. PLoS One (2015) 0.79
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B. PLoS One (2016) 0.79
Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia. J Clin Microbiol (2015) 0.78
Complete nucleotide sequence of a plasmid containing the botulinum neurotoxin gene in Clostridium botulinum type B strain 111 isolated from an infant patient in Japan. Mol Genet Genomics (2014) 0.78
Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Mol Ther Methods Clin Dev (2014) 0.78
A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins. Sci Rep (2015) 0.78
Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism. Curr Top Med Chem (2014) 0.77
Systemic colonization of clover (Trifolium repens) by Clostridium botulinum strain 2301. Front Microbiol (2015) 0.77
Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes. Genome Biol Evol (2016) 0.77
Tetanus neurotoxin utilizes two sequential membrane interactions for channel formation. J Biol Chem (2014) 0.77
Do Latin American scientific journals follow dual-use review policies? Biosecur Bioterror (2014) 0.77
The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions. Infect Immun (2015) 0.77
Botulinum neurotoxins: more and more diverse and fascinating toxic proteins. J Infect Dis (2013) 0.77
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. Tremor Other Hyperkinet Mov (N Y) (2014) 0.77
Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing. Toxins (Basel) (2015) 0.77
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins (Basel) (2017) 0.77
Identification and characterization of a novel botulinum neurotoxin. Nat Commun (2017) 0.77
High sensitivity detection of active botulinum neurotoxin by glyco-quantitative polymerase chain-reaction. Anal Chem (2014) 0.76
Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Toxins (Basel) (2017) 0.75
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation. Toxins (Basel) (2015) 0.75
Activity of botulinum neurotoxin type D (strain 1873) in human neurons. Toxicon (2015) 0.75
Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles. Hum Vaccin Immunother (2016) 0.75
A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. PLoS One (2017) 0.75
Clostridium botulinum toxin statement from the director of the California Department of Public Health. J Infect Dis (2014) 0.75
Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins. Toxins (Basel) (2016) 0.75
Reply to Korch. J Infect Dis (2014) 0.75
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody. Toxins (Basel) (2016) 0.75
Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression. Front Microbiol (2016) 0.75
Selection of RNA Aptamers Against Botulinum Neurotoxin Type A Light Chain Through a Non-Radioactive Approach. Appl Biochem Biotechnol (2016) 0.75
Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H. Toxins (Basel) (2017) 0.75
Embryonic Stem Cell-Derived Neurons Grown on Multi-Electrode Arrays as a Novel In vitro Bioassay for the Detection of Clostridium botulinum Neurotoxins. Front Pharmacol (2017) 0.75
Probiotic Microorganisms Inhibit Epithelial Cell Internalization of Botulinum Neurotoxin Serotype A. Toxins (Basel) (2016) 0.75
Spatial, Temporal, and Matrix Variability of Clostridium botulinum Type E Toxin Gene Distribution at Great Lakes Beaches. Appl Environ Microbiol (2015) 0.75
Botulinum neurotoxin serotypes detected by electrochemical impedance spectroscopy. Toxins (Basel) (2015) 0.75
A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. Sci Rep (2017) 0.75
The structure of the tetanus toxin reveals pH-mediated domain dynamics. EMBO Rep (2017) 0.75
Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis (2013) 3.00
Global occurrence of infant botulism, 1976-2006. Pediatrics (2008) 1.93
Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J Clin Microbiol (2009) 1.77
Attomolar detection of botulinum toxin type A in complex biological matrices. PLoS One (2008) 1.25
Clinical mimics of infant botulism. Pediatrics (2007) 1.25
Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl Environ Microbiol (2011) 1.15
Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol (2004) 1.12
Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol (2005) 1.04
Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One (2013) 1.00
First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol (2005) 1.00
Presence of soil-dwelling clostridia in commercial powdered infant formulas. J Pediatr (2009) 0.83
Universal and specific quantitative detection of botulinum neurotoxin genes. BMC Microbiol (2010) 0.82
Identical novel A5(B3') botulinum neurotoxin gene arrangements isolated from widely disparate geographical and patient sources suggest their independent origins. J Clin Microbiol (2010) 0.78
Concerning the article "An infant botulism case occurred in Italy". Infez Med (2010) 0.75